Cutia Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-472.27	-433.81	-1,964	-555.84	-319.58
Depreciation & Amortization	44.16	42.9	41.47	18.7	9.79
Other Amortization	1.66	1.66	1.01	0.22	-
Loss (Gain) From Sale of Assets	1.33	0.36	0.25	-	-
Loss (Gain) From Sale of Investments	-8.66	-21.56	-1.72	-7.68	5.2
Stock-Based Compensation	49.82	68.62	132.35	100.03	41.11
Other Operating Activities	41.96	0.66	1,415	237.48	137.65
Change in Accounts Receivable	9.07	-37.4	-62.85	-0.1	-
Change in Inventory	-37.98	-32.82	-25.32	-18.19	-1.8
Change in Accounts Payable	-1.22	-13.84	64.8	21.56	0.42
Change in Unearned Revenue	-	-0.4	-	-	-
Change in Other Net Operating Assets	3.61	-17.36	17.94	-32.37	-32.66
Operating Cash Flow	-368.53	-442.98	-381.31	-236.19	-159.88
Capital Expenditures	-21.36	-22.57	-55.73	-134.35	-24.32
Sale of Property, Plant & Equipment	0.01	0.01	0.01	-	-
Sale (Purchase) of Intangibles	-2.73	-3.11	-0.18	-0.96	-1.57
Investment in Securities	303.14	328.59	-176.13	609.02	-375.05
Other Investing Activities	28.94	13.15	28.46	-11.64	-9.71
Investing Cash Flow	308.01	316.07	-203.58	462.07	-410.65
Long-Term Debt Issued	-	203.45	189.2	-	-
Long-Term Debt Repaid	-	-143.11	-11.57	-6.88	-3.09
Net Debt Issued (Repaid)	9.33	60.34	177.63	-6.88	-3.09
Issuance of Common Stock	4.44	4.74	422.52	-	-
Repurchase of Common Stock	-13.86	-13.86	-	-	-
Other Financing Activities	-6.94	-13.39	-11.83	-3.37	-0.15
Financing Cash Flow	-7.03	37.84	588.32	-10.25	480.76
Foreign Exchange Rate Adjustments	0.34	1.62	3.82	47.11	-7.27
Net Cash Flow	-67.21	-87.45	7.25	262.74	-97.04
Free Cash Flow	-389.88	-465.56	-437.04	-370.54	-184.2
Free Cash Flow Margin	-155.75%	-166.50%	-317.56%	-3260.10%	-9038.08%
Free Cash Flow Per Share	-1.24	-1.52	-2.14	-4.63	-2.30
Cash Interest Paid	6.71	7.4	1.8	-	-
Levered Free Cash Flow	-191.81	-291.48	-250.48	-203.12	-
Unlevered Free Cash Flow	-184.96	-284.69	-247.68	-202.04	-
Change in Working Capital	-26.53	-101.81	-5.42	-29.1	-34.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.